---
layout: default
title: Reinforcement Learning for Target Zone Blood Glucose Control
---

# Reinforcement Learning for Target Zone Blood Glucose Control

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2508.03875" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2508.03875v1</a>
  <a href="https://arxiv.org/pdf/2508.03875.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2508.03875v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2508.03875v1', 'Reinforcement Learning for Target Zone Blood Glucose Control')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: David H. Mguni, Jing Dong, Wanrong Yang, Ziquan Liu, Muhammad Salman Haleem, Baoxiang Wang

**åˆ†ç±»**: cs.LG

**å‘å¸ƒæ—¥æœŸ**: 2025-08-05

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºå¼ºåŒ–å­¦ä¹ æ¡†æ¶ä»¥è§£å†³1å‹ç³–å°¿ç—…è¡€ç³–æ§åˆ¶é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)** **æ”¯æŸ±å…«ï¼šç‰©ç†åŠ¨ç”» (Physics-based Animation)**

**å…³é”®è¯**: `å¼ºåŒ–å­¦ä¹ ` `1å‹ç³–å°¿ç—…` `è¡€ç³–æ§åˆ¶` `ä¸ªæ€§åŒ–æ²»ç–—` `å†³ç­–æ”¯æŒ` `ç”Ÿç†çŠ¶æ€` `é©¬å°”å¯å¤«å†³ç­–è¿‡ç¨‹`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰çš„å¼ºåŒ–å­¦ä¹ æ–¹æ³•åœ¨å¤„ç†1å‹ç³–å°¿ç—…çš„è¡€ç³–æ§åˆ¶æ—¶ï¼Œé¢ä¸´å¹²é¢„æ•ˆæœå»¶è¿Ÿå’Œå¼‚è´¨æ€§çš„é—®é¢˜ï¼Œéš¾ä»¥å®ç°ä¸ªæ€§åŒ–æ²»ç–—ã€‚
2. æœ¬æ–‡æå‡ºäº†ä¸€ç§æ–°é¢–çš„å¼ºåŒ–å­¦ä¹ æ¡†æ¶ï¼Œé€šè¿‡ç»“åˆå†²åŠ¨æ§åˆ¶å’Œåˆ‡æ¢æ§åˆ¶ï¼Œæ•æ‰æ²»ç–—çš„å¤æ‚æ—¶é—´åŠ¨æ€ï¼Œä»¥æ”¯æŒT1DMçš„å†³ç­–åˆ¶å®šã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼Œè¯¥æ¡†æ¶åœ¨ç®€åŒ–çš„T1DMæ§åˆ¶ä»»åŠ¡ä¸­æ˜¾è‘—é™ä½äº†è¡€ç³–æ°´å¹³è¿è§„ç‡ï¼Œä»22.4%é™è‡³10.8%ï¼Œå±•ç¤ºäº†å…¶æœ‰æ•ˆæ€§ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨åŒ»ç–—ä¿å¥ä¸­ï¼Œç®¡ç†ç”Ÿç†å˜é‡ä»¥ä¿æŒåœ¨ä¸´åºŠå®‰å…¨çš„ç›®æ ‡åŒºé—´æ˜¯ä¸€ä¸ªæ ¸å¿ƒæŒ‘æˆ˜ï¼Œå°¤å…¶æ˜¯å¯¹äº1å‹ç³–å°¿ç—…ï¼ˆT1DMï¼‰ç­‰æ…¢æ€§ç–¾ç—…ã€‚å¼ºåŒ–å­¦ä¹ ï¼ˆRLï¼‰ä¸ºä¸ªæ€§åŒ–æ²»ç–—æä¾›äº†å¸Œæœ›ï¼Œä½†åœ¨å¹²é¢„çš„å»¶è¿Ÿå’Œå¼‚è´¨æ€§æ•ˆæœæ–¹é¢é¢ä¸´å›°éš¾ã€‚æœ¬æ–‡æå‡ºäº†ä¸€ç§æ–°é¢–çš„RLæ¡†æ¶ï¼Œæ—¨åœ¨ç ”ç©¶å’Œæ”¯æŒT1DMæŠ€æœ¯ä¸­çš„å†³ç­–åˆ¶å®šï¼Œå¦‚è‡ªåŠ¨èƒ°å²›ç´ è¾“é€ã€‚è¯¥æ–¹æ³•é€šè¿‡ç»Ÿä¸€ä¸¤ç§æ§åˆ¶æ¨¡å¼ï¼Œæ•æ‰æ²»ç–—çš„å¤æ‚æ—¶é—´åŠ¨æ€ï¼Œæ ¸å¿ƒæ˜¯ä¸€ä¸ªå—çº¦æŸçš„é©¬å°”å¯å¤«å†³ç­–è¿‡ç¨‹ï¼Œå¢å¼ºäº†ç”Ÿç†çŠ¶æ€ç‰¹å¾ï¼Œä½¿å¾—åœ¨ä¸´åºŠå’Œèµ„æºçº¦æŸä¸‹å®‰å…¨åœ°å­¦ä¹ ç­–ç•¥ã€‚è¯¥æ¡†æ¶è€ƒè™‘äº†ç”Ÿç‰©å­¦ä¸Šç°å®çš„å› ç´ ï¼ŒåŒ…æ‹¬èƒ°å²›ç´ è¡°å‡ï¼Œä»è€Œç”Ÿæˆæ›´ç¬¦åˆå®é™…æ²»ç–—è¡Œä¸ºçš„ç­–ç•¥ã€‚è™½ç„¶ä¸æ‰“ç®—ç”¨äºä¸´åºŠéƒ¨ç½²ï¼Œä½†æœ¬ç ”ç©¶ä¸ºæœªæ¥å®‰å…¨ä¸”å…·æœ‰æ—¶é—´æ„è¯†çš„RLåœ¨åŒ»ç–—ä¸­çš„åº”ç”¨å¥ å®šäº†åŸºç¡€ã€‚æˆ‘ä»¬æä¾›äº†æ”¶æ•›çš„ç†è®ºä¿è¯ï¼Œå¹¶åœ¨ä¸€ä¸ªç®€åŒ–çš„T1DMæ§åˆ¶ä»»åŠ¡ä¸­å±•ç¤ºäº†ç»éªŒä¸Šçš„æ”¹è¿›ï¼Œå°†è¡€ç³–æ°´å¹³è¿è§„ç‡ä»22.4%ï¼ˆç°æœ‰æŠ€æœ¯ï¼‰é™ä½è‡³æœ€ä½10.8%ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³1å‹ç³–å°¿ç—…æ‚£è€…åœ¨è¡€ç³–æ§åˆ¶ä¸­é¢ä¸´çš„å»¶è¿Ÿå’Œå¼‚è´¨æ€§å¹²é¢„æ•ˆæœçš„é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•éš¾ä»¥é€‚åº”å¤æ‚çš„ç”Ÿç†åŠ¨æ€ï¼Œå¯¼è‡´æ²»ç–—æ•ˆæœä¸ä½³ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šæå‡ºäº†ä¸€ç§æ–°é¢–çš„å¼ºåŒ–å­¦ä¹ æ¡†æ¶ï¼Œé€šè¿‡ç»“åˆå†²åŠ¨æ§åˆ¶å’Œåˆ‡æ¢æ§åˆ¶ï¼Œèƒ½å¤Ÿæ›´å¥½åœ°æ•æ‰æ²»ç–—çš„æ—¶é—´åŠ¨æ€ï¼Œæ”¯æŒä¸ªæ€§åŒ–å†³ç­–ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šæ•´ä½“æ¶æ„åŒ…æ‹¬ä¸€ä¸ªå—çº¦æŸçš„é©¬å°”å¯å¤«å†³ç­–è¿‡ç¨‹ï¼Œå¢å¼ºäº†ç”Ÿç†çŠ¶æ€ç‰¹å¾ï¼Œç¡®ä¿åœ¨ä¸´åºŠå’Œèµ„æºçº¦æŸä¸‹å®‰å…¨åœ°å­¦ä¹ ç­–ç•¥ã€‚ä¸»è¦æ¨¡å—åŒ…æ‹¬çŠ¶æ€ç‰¹å¾æå–ã€ç­–ç•¥å­¦ä¹ å’Œå†³ç­–æ‰§è¡Œã€‚

**å…³é”®åˆ›æ–°**ï¼šæœ€é‡è¦çš„åˆ›æ–°ç‚¹åœ¨äºå°†å†²åŠ¨æ§åˆ¶ä¸åˆ‡æ¢æ§åˆ¶ç›¸ç»“åˆï¼Œèƒ½å¤ŸåŒæ—¶å¤„ç†å¿«é€Ÿå’Œé•¿æœŸçš„æ²»ç–—å¹²é¢„ï¼Œæ˜¾è‘—æé«˜äº†ç­–ç•¥çš„é€‚åº”æ€§å’Œå®‰å…¨æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨æŠ€æœ¯ç»†èŠ‚ä¸Šï¼Œè®¾è®¡äº†é€‚åº”ç”Ÿç†çŠ¶æ€å˜åŒ–çš„æŸå¤±å‡½æ•°ï¼Œå¹¶è€ƒè™‘äº†èƒ°å²›ç´ è¡°å‡ç­‰ç”Ÿç‰©å­¦å› ç´ ï¼Œä»¥ç¡®ä¿ç”Ÿæˆçš„ç­–ç•¥æ›´ç¬¦åˆå®é™…æ²»ç–—è¡Œä¸ºã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœæ˜¾ç¤ºï¼Œæ‰€æå‡ºçš„æ¡†æ¶åœ¨ç®€åŒ–çš„T1DMæ§åˆ¶ä»»åŠ¡ä¸­ï¼ŒæˆåŠŸå°†è¡€ç³–æ°´å¹³è¿è§„ç‡ä»22.4%é™ä½è‡³10.8%ï¼Œå±•ç°å‡ºæ˜¾è‘—çš„æ€§èƒ½æå‡ã€‚è¿™ä¸€æˆæœä¸ºæœªæ¥åœ¨åŒ»ç–—é¢†åŸŸåº”ç”¨å¼ºåŒ–å­¦ä¹ æä¾›äº†æœ‰åŠ›çš„æ”¯æŒã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬æ…¢æ€§ç—…ç®¡ç†ã€ä¸ªæ€§åŒ–åŒ»ç–—å’Œè‡ªåŠ¨åŒ–æ²»ç–—ç³»ç»Ÿã€‚é€šè¿‡æä¾›ä¸€ä¸ªå®‰å…¨ä¸”æœ‰æ•ˆçš„å†³ç­–æ”¯æŒæ¡†æ¶ï¼Œèƒ½å¤Ÿæ”¹å–„1å‹ç³–å°¿ç—…æ‚£è€…çš„ç”Ÿæ´»è´¨é‡ï¼Œå¹¶ä¸ºæœªæ¥çš„åŒ»ç–—æŠ€æœ¯å‘å±•å¥ å®šåŸºç¡€ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Managing physiological variables within clinically safe target zones is a central challenge in healthcare, particularly for chronic conditions such as Type 1 Diabetes Mellitus (T1DM). Reinforcement learning (RL) offers promise for personalising treatment, but struggles with the delayed and heterogeneous effects of interventions. We propose a novel RL framework to study and support decision-making in T1DM technologies, such as automated insulin delivery. Our approach captures the complex temporal dynamics of treatment by unifying two control modalities: \textit{impulse control} for discrete, fast-acting interventions (e.g., insulin boluses), and \textit{switching control} for longer-acting treatments and regime shifts. The core of our method is a constrained Markov decision process augmented with physiological state features, enabling safe policy learning under clinical and resource constraints. The framework incorporates biologically realistic factors, including insulin decay, leading to policies that better reflect real-world therapeutic behaviour. While not intended for clinical deployment, this work establishes a foundation for future safe and temporally-aware RL in healthcare. We provide theoretical guarantees of convergence and demonstrate empirical improvements in a stylised T1DM control task, reducing blood glucose level violations from 22.4\% (state-of-the-art) to as low as 10.8\%.

